ILK is more established in the field and has been proposed as a potential anti-cancer therapeutic target [56] being involved in tumor growth and invasion [57,58] in many types of cancers while there was also a report of a suppressive effect seen on BC cells following ectopic expression of ILK [59]. The gene discussed is ILK; the disease is cancer.